ispor 13th annual european congress disclosure information

ISPOR 13TH ANNUAL EUROPEAN CONGRESS DISCLOSURE INFORMATION

Research Presentations Financial Disclosure Statements

The International Society for Pharmacoeconomics and Outcomes Research asked all abstract contributors to disclose fi nancial support for their research. The following fi nancial support was declared:

REFERENCE CODE FINANCIAL SUPPORT

AD1 AstraZeneca, Madrid, SpainAD2 Amgen, Stockholm, SwedenAD3 Abbott, Abbott Park, IL, USAAD4 NoneBI1 Pfi zer Oncology, New York, NY, USABI2 NoneBI3 NoneBI4 Israel National Institution for Health Policy and Health Service Research,

Tel-Hashomer, IsraelBL1 UCB Pharma Oy Finland, Espoo, FinlandBL2 Bristol-Myers Squibb, Buenos Aires, ArgentinaBL3 ZON-MW, Den Haag, The NetherlandsBL4 Wyeth Pharmaceuticals BV, Hoofddorp, The NetherlandsCN1 NoneCN2 Dutch Health Care Insurance Board, Diemen, The NetherlandsCN3 NoneCN4 German Agency for Health Technology Assessment (DAHTA@DIMDI),

Cologne, GermanyEQ1 NoneEQ2 EPAC Patients’ Organization (ONLUS), Milan, ItalyEQ3 Conselho Nacional de Desenvolvimento Científi co e Tecnológico

(CNPQ), Brasília, BrazilEQ4 NoneHT1 NoneHT2 NoneHT3 NoneHT4 Double Helix Consulting, London, UKIR1 NoneIR2 NoneIR3 NoneIR4 Neurosearch, Gothenburg, SwedenMA1 NoneMA2 NoneMA3 ALCON Couvreur SA-NV, Puurs, BelgiumMA4 NoneMO1 NIHR HTA Programme on behalf of NICE, London/Manchester, UKMO2 NoneMO3 Center for Translational and Molecular Medicine, Eindhoven, The

NetherlandsMO4 NoneMT1 NoneMT2 Roche Products Limited, Welwyn Garden City, UKMT3 Lilly Deutschland GmbH, Bad Homburg, GermanyMT4 NoneNI1 NoneNI2 NoneNI3 Amgen, London, UK; AstraZeneca, London, UK; BMS, London, UK;

Celgene, London, UK; GSK, London, UK; Lilly, London, UK; Merck, London, UK; Merck-Serono, London, UK; Pfi zer, London, UK; Sanofi -Aventis, London, UK; Wyeth, London, UK; spcorp, London, UK

NI4 NonePCN1 AstraZeneca UK Ltd., Luton, UKPCN2 Eisai, Inc., Woodcliff Lake, NJ, USAPCN3 Eisai, Inc., Woodcliff Lake, NJ, USAPCN4 Eisai, Inc., Woodcliff Lake, NJ, USAPCN5 Schering-Plough, São Paulo, BrazilPCN6 NonePCN7 NonePCN8 Amgen, Newbury Park, CA, USAPCN9 Roche, Paris, FrancePCN10 NonePCN11 AstraZeneca UK Ltd., Luton, UKPCN12 Sanofi -Aventis R&D, Vitry, France

PCN13 NonePCN14 Amgen Europe, Zug, SwitzerlandPCN15 GlaxoSmithKline, London, UKPCN16 F. Hoffman La Roche, Basel, SwitzerlandPCN17 Sanofi -Aventis R&D, Vitry, FrancePCN18 NonePCN19 NonePCN20 F. Hoffmann-La Roche Pharmaceuticals, Basel, SwitzerlandPCN21 F. Hoffmann-La Roche Pharmaceuticals, Basel, SwitzerlandPCN22 NonePCN23 F. Hoffmann-La Roche Pharmaceuticals AG, Basel, SwitzerlandPCN24 NonePCN26 Roche, São Paulo, BrazilPCN27 Roche Farmacêutica Química, Portugal, Amadora, PortugalPCN28 NonePCN29 GlaxoSmithKline, Collegeville, PA, USAPCN31 NonePCN32 NonePCN33 AstraZeneca, Zagreb, CroatiaPCN34 Roche Polska Sp z o.o, Warsaw, PolandPCN35 Merck-Serono, Madrid, SpainPCN36 Eisai, Inc., Woodcliff Lake, NJ, USAPCN37 AstraZeneca BV, Zoetermeer, The NetherlandsPCN38 NonePCN39 NonePCN40 Roche Farmacêutica Química, Portugal, Lisboa, PortugalPCN41 Genentech, So San Francisco, CA, USAPCN42 Productos Roche S.A. de C.V., México, MexicoPCN43 F. Hoffmann-La Roche Ltd., Basel, SwitzerlandPCN44 F. Hoffmann-La Roche Ltd., Basel, SwitzerlandPCN45 AstraZeneca, Wilmington, DE, USAPCN46 Genomic Health, Inc., Redwood City, CA, USAPCN47 Essex Pharma GmbH, Munich, GermanyPCN48 Steba Biotech S.A., Luxembourg, Luxembourg; LA-SER Europe Ltd.,

London, UKPCN49 Pfi zer, Inc., New York, NY, USAPCN50 Abbott Laboratories, Abbott Park, IL, USAPCN51 Sanofi Pasteur MSD, Lyon, FrancePCN52 Universitätsklinikum Erlangen, Erlangen, GermanyPCN53 NonePCN54 NonePCN55 NonePCN56 NonePCN57 Malaysian Ministry of Higher Education, Kuala Lumpur, MalaysiaPCN58 Amgen, Vienna, AustriaPCN59 GlaxoSmithKline, Marly le Roi, FrancePCN60 Agency for Healthcare Research and Quality, Rockville, MD, USAPCN61 NonePCN62 Amgen, Vienna, AustriaPCN63 Amgen, Vienna, AustriaPCN64 Amgen, Vienna, AustriaPCN65 Emilia Romagna Region, Ferrara, ItalyPCN66 Roche, Shanghai, ChinaPCN67 Fresenius Biotech GmbH, Munich, GermanyPCN68 Amgen, Europe, Zug, SwitzerlandPCN69 Bristol-Myers Squibb, Madrid, SpainPCN70 Roche, São Paulo, BrazilPCN71 Novartis Pharmaceuticals, Basel, SwitzerlandPCN72 Novartis Pharmaceuticals, Basel, SwitzerlandPCN73 NonePCN74 Novartis Pharmaceuticals, Basel, SwitzerlandPCN75 NonePCN76 Johnson & Johnson, Madrid, SpainPCN77 Novartis Pharmaceuticals, São Paulo, Brazil

© 2010, International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 1098-3015/10/A481 A481–A489 A481

Volume 13 • Number 7 • 2010V A L U E I N H E A L T H


A482 ISPOR 13th Annual European Congress Disclosure Information

PCN78 NonePCN79 NonePCN80 NonePCN81 NonePCN82 NCI, Bethesda, MD, USAPCN83 Amgen Europe (GmbH), Zug, SwitzerlandPCN84 Roche, Paris, FrancePCN85 NonePCN86 NonePCN87 NonePCN88 NonePCN89 NonePCN90 NonePCN91 Roche Poland Sp z o.o., Warsaw, PolandPCN92 NonePCN93 Roche, São Paulo, BrazilPCN94 F. Hoffmann—La Roche Ltd., Basel, SwitzerlandPCN95 Hospira UK Limited, Royal Leamington Spa, UKPCN96 Abraxis BioScience, Paris, FrancePCN97 Roche Products Limited, Welwyn Garden City,

UKPCN98 NonePCN99 Novartis, Dorval, QC, CanadaPCN100 AstraZeneca, Södertälje, SwedenPCN101 BMS, Brussels, BelgiumPCN102 Instituto Salud Carlos III, Madrid, SpainPCN103 GSK, Budapest, HungaryPCN104 F. Hoffmann-La Roche AG, Basel, SwitzerlandPCN105 F. Hoffmann-La Roche AG, Basel, SwitzerlandPCN106 F. Hoffmann-La Roche AG, Basel, SwitzerlandPCN107 F. Hoffmann-La Roche AG, Basel, SwitzerlandPCN108 F. Hoffmann-La Roche AG, Basel, SwitzerlandPCN109 Abbott Laboratories, Abbott Park, IL, USAPCN110 AstraZeneca, Macclesfi eld, UKPCN111 BMS, Paris, FrancePCN112 Amgen, Thousand Oaks, CA, USAPCN113 Bristol-Myers Squibb, Braine-l’Alleud, BelgiumPCN114 NonePCN115 NonePCN116 F. Hoffmann-La Roche Ltd., Basel, SwitzerlandPCN117 GlaxoSmithKline, Uxbridge, UKPCN118 Novartis Pharmaceuticals Corporation, Florham Park, NJ,

USAPCN119 NonePCN120 GlaxoSmithKline BV, Zeist, The NetherlandsPCN121 AstraZeneca, Macclesfi eld, UKPCN122 NonePCN123 NonePCN124 NonePCN125 NonePCN126 Boehringer Ingelheim GmbH, Ingelheim, GermanyPCN127 NonePCN128 NonePCN129 NonePCN130 Bayer Schering Pharma, Diegem, BelgiumPCN131 NonePCN132 F. Hoffmann-La Roche Ltd., Basel, SwitzerlandPCN133 AstraZeneca, Madrid, SpainPCN134 NonePCN135 NonePCN136 Shiraz University of Medical Sciences, Shiraz, IranPCN137 National Cancer Center, Goyang-si, South KoreaPCN138 NonePCN140 NonePCN141 Ministry of Labour and Social Policy—European Social Fund, Warsaw,

PolandPCN142 NonePCN143 NonePCN144 Amgen, Newbury Park, CA, USAPCN145 Roche Hellas, Athens, GreecePCN146 Amgen, Thousand Oaks, CA, USAPCN147 Bayer, Taipei, TaiwanPCN148 NonePCN149 NonePCN150 Novartis Pharma AG, Basle, SwitzerlandPCN151 NonePCN152 Merck Serono, London, UKPCN153 Eli Lilly and Company, Indiana, IN, USAPCN154 None

PCN156 NonePCN157 NonePCN158 Genomic Health, Inc., Redwood City, CA, USAPCN160 Genentech, Inc., South San Francisco, CA, USAPCN161 Oncotyrol—Center for Personalized Cancer Medicine, Innsbruck,

AustriaPCN162 Pfi zer Oncology, New York, NY, USAPCN163 NonePCN164 NonePCN165 NonePCN166 NonePCN167 ZONMw, The Hague, The NetherlandsPCV1 NonePCV2 NonePCV3 NonePCV4 NonePCV5 NonePCV6 NonePCV7 NonePCV8 Abbott Laboratories, Abbott Park, IL, USAPCV9 Abbott Laboratories, Abbott Park, IL, USAPCV10 Medtronic International, Tolochenaz, SwitzerlandPCV12 Merck, Whitehouse Station, NJ, USAPCV13 Eisai Inc., Woodcliff Lake, NJ, USAPCV14 NonePCV15 AstraZeneca Pharma Poland Sp. z o.o., Warsaw, PolandPCV16 Pfi zer Inc., New York, NY, USAPCV17 Pfi zer Inc., New York, NY, USAPCV18 Merck and Company, Inc., Whitehouse Station, NJ, USAPCV19 CIHR, Ottawa, QC, CanadaPCV20 CIHR, Ottawa, QC, CanadaPCV21 Sanofi -Aventis, Paris, FrancePCV22 NonePCV23 AstraZeneca R&D, Mölndal, SwedenPCV24 NonePCV25 Kantar Health, New York, NY, USAPCV26 NonePCV27 NonePCV28 Pfi zer Inc., New York, NY, USAPCV29 Sanofi -Aventis, Paris, France; Qatar Telecommunications Company,

Doha, QatarPCV30 AstraZeneca, Madrid, SpainPCV31 Novartis Pharma, Barcelona, SpainPCV32 Cook Medical, Bjaeverskov, DenmarkPCV33 Medtronic, Tolochenaz, SwitzerlandPCV34 AstraZeneca, Naucalpan, MexicoPCV35 GSK Commercial Sp. z o.o., Warsaw, PolandPCV36 NonePCV37 NonePCV38 NonePCV39 GE HealthCare, Barrington, IL, USAPCV40 GE HealthCare, Barrington, IL, USAPCV41 Ministry of Health NS 9675–3/2008, Prague, Czech RepublicPCV42 NonePCV43 Abbott Laboratories, Abbott Park, IL, USAPCV44 Abbott Laboratories, Abbott Park, IL, USAPCV45 Astra Zeneca, Istanbul, TurkeyPCV46 Medtronic, Madrid, SpainPCV47 Lilly Korea, Seoul, South KoreaPCV48 NonePCV49 Sanofi -Aventis Hellas, Athens, GreecePCV50 Boehringer Ingelheim, Stockholm, Sweden; Östergötland county council,

Linköping, SwedenPCV51 NonePCV52 Bayer Healthcare Pharmaceutical, Wayne, NJ, USAPCV53 SERVIER, Riyadh, Saudi ArabiaPCV54 Pfi zer Inc., New York, NY, USAPCV55 NonePCV56 GE Healthcare, Princeton, NJ, USAPCV57 National Research Foundation, Pretoria, South AfricaPCV58 NonePCV59 NonePCV60 Sanofi -Aventis, Madrid, SpainPCV61 NonePCV62 Medtronic International Trading Sàrl, Tolochenaz, SwitzerlandPCV63 AIAC, Roma, ItalyPCV64 NonePCV65 Vifor Pharma, Glattbrugg, SwitzerlandPCV66 Boehringer Ingelheim Italy, Milan, Italy



ISPOR 13th Annual European Congress Disclosure Information A483

PCV67 GlaxoSmithKline, Moscow, RussiaPCV68 Center for Translational Molecular Medicine, Eindhoven, The

Netherlands; The Netherlands Heart Foundation, Den Haag, The Netherlands

PCV69 Pfi zer Portugal, Oeiras, PortugalPCV70 Sanofi -Aventis Canada Inc., Laval, QC, CanadaPCV71 Medtronic, Tolochenaz, SwitzerlandPCV72 Merck & Co Inc., Whitehouse Station, NJ, USAPCV73 Novartis Pharma AG, Basel, SwitzerlandPCV74 Medco Health Solutions, Inc., Franklin Lakes, NJ, USAPCV75 Sanofi -Aventis, Paris, FrancePCV76 Sanofi -Aventis, Mexico City, MexicoPCV77 Merck, Whitehouse Station, NJ, USAPCV78 Servier Austria GmbH, Vienna, AustriaPCV79 The Sanofi -Aventis Korea Co Ltd., Seoul, South KoreaPCV80 NonePCV81 Ministry of Science and Higher Education, Warszawa, Poland; Jagiellonian

University, Krakow, PolandPCV82 The National Board of Health and Welfare, Stockholm, SwedenPCV83 NonePCV84 Medtronic, Madrid, SpainPCV85 Eli Lilly and Co., Alcobendas, SpainPCV86 Sanofi -Aventis Hellas, Athens, GreecePCV87 Medtronic, Tolochenaz, SwitzerlandPCV89 Sanofi -Aventis, Guildford, UKPCV90 AstraZeneca, Södertälje, SwedenPCV91 AstraZeneca, Södertälje, SwedenPCV92 Pfi zer Limited, Surrey, UKPCV93 Bayer, Bratislava, Slovak RepublicPCV94 Center for Translational Molecular Medicine, Eindhoven, The

Netherlands; The Netherlands Heart Foundation, Den Haag, The Netherlands

PCV95 NonePCV96 NonePCV97 Daiichi Sankyo Company, Ltd., Tokyo, Japan; Eli Lilly and Company,

Indianapolis, IN, USAPCV98 Robert Wood Johnson Foundation, Princeton, NJ, USAPCV99 Sanofi -Aventis, Gouda, The NetherlandsPCV100 Daiichi Sankyo Company, Ltd., Tokyo, Japan; Eli Lilly and Company,

Indianapolis, IN, USAPCV101 NonePCV102 NonePCV103 NonePCV104 AstraZeneca Canada Inc., Mississauga, ON, CanadaPCV105 NonePCV106 Registrat-Mapi, Lyon, FrancePCV107 Bayer HealthCare LLC, Morristown, NJ, USAPCV108 Pfi zer Inc., New York, NY, USAPCV109 NonePCV110 Medtronic Italia S.p.A., Sesto San Giovanni (MI), ItalyPCV111 Lowe’s, Charlotte, NC, USAPCV112 AstraZeneca Pharmaceuticals LP, Wilmington, DE, USAPCV113 NonePCV114 Servier, Bucarest, RomaniaPCV115 NonePCV116 Medtronic, Madrid, SpainPCV117 Pfi zer Inc., New York, NY, USAPCV118 Hamdard University, Islamabad, PakistanPCV119 Boehringer Ingelheim France, Paris, FrancePCV120 NonePCV121 AstraZeneca, Madrid, SpainPCV122 National Institute for Health Policy and Health Services Research, Ramat

Gan, IsraelPCV123 NonePCV124 NonePCV125 Pfi zer Spain, Madrid, SpainPCV126 Eli Lilly, Indianapolis, IN, USAPCV127 NonePCV128 Techniker Health Insurance, Hamburg, GermanyPCV129 NHS North Yorkshire and York, York, UKPCV130 Daiichi Sankyo Company, Ltd., Tokyo, Japan; Eli Lilly and Company,

Indianapolis, IN, USAPCV131 Daiichi Sankyo Company, Ltd., Tokyo, Japan; Eli Lilly and Company,



Indianapolis, IN, USAPCV134 None

PCV135 NonePCV136 Sanofi -Aventis Hellas, Athens, GreecePCV137 Bayer Schering Pharma AG, Wuppertal, GermanyPCV138 Pfi zer Inc., New York, NY, USAPCV139 NonePCV140 NonePCV141 Novartis Pharma AG, Basel, SwitzerlandPCV142 Daiichi Sankyo, Inc., Parsippany, NJ, USAPDB1 Novo Nordisk Inc., Princeton, NJ, USAPDB2 Bristol-Myers Squibb, Madrid, SpainPDB3 NonePDB4 Novo Nordisk (China) Pharmaceuticals Co., Ltd., Beijing, ChinaPDB5 NonePDB6 NonePDB7 Sanofi -Aventis Deutschland GmbH, Berlin, GermanyPDB8 Eli Lilly and Company, Indianapolis, IN, USAPDB9 Eli Lilly and Co. Ltd., Indianapolis, IN, USAPDB10 IMS Health, Frankfurt, GermanyPDB11 Top Institute Pharma, Leiden, OH, The NetherlandsPDB12 Eli Lilly and Company, Indianapolis, IN, USAPDB13 Bristol-Myers Squibb, São Paulo, BrazilPDB14 Bristol-Myers Squibb, São Paulo, BrazilPDB15 NonePDB16 Sanofi -Aventis Deutschland GmbH, Berlin, GermanyPDB17 Novo Nordisk Sp. zo.o., Warsawa, PolandPDB18 Novartis Pharma, Barcelona, SpainPDB19 Bristol-Myers Squibb, Mexico City, MexicoPDB20 Pfi zer Pharmaceuticals, Istanbul, TurkeyPDB21 Sanofi -Aventis, Madrid, SpainPDB22 BAYER HEALTHCARE, Barcelona, SpainPDB23 Hamadard University, Islamabad, PakistanPDB24 Novo Nordisk, Budapest, HungaryPDB25 NonePDB26 Pfi zer Pharmaceuticals Korea Ltd., Seoul, South KoreaPDB27 BMS, Lisbon, PortugalPDB28 NonePDB29 Novo Nordisk Poland, Warsaw, PolandPDB30 Nycomed Russia-CIS, Moscow, RussiaPDB31 Medtronic Italia, Sesto San Giovanni, ItalyPDB32 Novo Nordisk Hungary Ltd., Budapest, HungaryPDB33 Eli Lilly and Company, Indianapolis, IN, USAPDB34 Merck Serono S.A., Geneva, SwitzerlandPDB35 Medtronic of Canada, Brampton, ON, CanadaPDB36 Amylin Pharmaceuticals, Inc., San Diego, CA, USAPDB37 Bristol-Myers Squibb, Braine l’Alleud, BelgiumPDB38 Novo Nordisk, Mainz, GermanyPDB39 Novo Nordisk Ltd., Crawley, UKPDB40 Johnson and Johnson, Raritan, NJ, USAPDB41 NonePDB42 Novo Nordisk, Mainz, GermanyPDB43 Novo Nordisk Pharma Sp. z o.o., Warsaw, PolandPDB44 Bristol-Myers Squibb, Braine l’Alleud, BelgiumPDB45 Bristol-Myers Squibb, Madrid, Spain; AstraZeneca, Madrid, SpainPDB46 NonePDB47 NonePDB48 National Institute for Health and Disability Insurance, Brussels, BelgiumPDB49 Novo Nordisk, Moscow, RussiaPDB50 AstraZeneca, Mölndal, SwedenPDB51 Eli Lilly, Erl Wood Manor, UK; Amylin Pharmaceuticals, San Diego, CA,

USAPDB52 NonePDB53 Pfi zer Spain, Madrid, SpainPDB54 Sanofi -Aventis Deutschland GmbH, Berlin, GermanyPDB55 Sanofi -Aventis, Berlin, GermanyPDB56 NonePDB57 Sanofi -Aventis, Berlin, GermanyPDB58 NonePDB59 Sanofi -Aventis Deutschland GmbH, Berlin, GermanyPDB60 Sanofi -Aventis Deutschland GmbH, Berlin, GermanyPDB61 Novo Nordisk, Sofi a, BulgariaPDB62 Bristol-Myers Squibb, São Paulo, BrazilPDB63 Novo Nordisk Pharma, Bucharest, RomaniaPDB64 Novo Nordisk Inc., Princeton, NJ, USAPDB65 NonePDB66 NonePDB67 NonePDB68 AstraZeneca Nordic, Södertälje, SwedenPDB69 NonePDB70 Novo Nordisk (China) Pharmaceuticals Co., Ltd., Beijing, China




PDB71 AstraZeneca Sweden, Södertälje, SwedenPDB72 Pfi zer, Sollentuna, SwedenPDB73 AstraZeneca, Zaventem, Belgium; Bristol-Myers Squibb, Paris, FrancePDB74 Novartis Pharma AG, Basel, SwitzerlandPDB75 Johnson & Johnson, Raritan, NJ, USAPDB76 Bristol-Myers Squibb, São Paulo, BrazilPDB77 NonePDB78 Novo Nordisk Scandinavia AB, Malmö, SwedenPDB79 Sanofi -Aventis, Paris, FrancePDB80 Lilly Deutschland GmbH, Bad Homburg, GermanyPDB81 Merck & Co., Inc., Whitehouse Station, NJ, USAPDB82 Novo Nordisk gmbh, Mainz, GermanyPDB83 Eli Lilly and Company, Indianapolis, IN, USAPDB84 Novartis, Barcelona, SpainPDB85 Quintiles, Hoofddorp, The NetherlandsPDB86 NonePDB87 Bristol-Myers Squibb, München, Germany; AstraZeneca, Wedel,

GermanyPDB88 NonePDB89 NonePDB90 Centers for Disease Control and Prevention, Atlanta, GA, USAPDB91 Bristol-Myers Squibb, São Paulo, BrazilPDB92 NonePDB93 Medco Health Solutions, Franklin Lakes, NJ, USAPDB94 NonePDB95 NonePGI1 NonePGI2 Roche, São Paulo, BrazilPGI3 NonePGI4 GlaxoSmithKline, Philadelphia, PA, USAPGI5 MSD, São Paulo, BrazilPGI6 GE Healthcare, Waukesha, WI, USAPGI7 Pfi zer, Madrid, SpainPGI8 Sanofi Pasteur MSD, Maidenhead, UKPGI9 AstraZeneca Nordic, Södertälje, SwedenPGI10 Bristol Myers Squibb, Braine l’Alleud, BelgiumPGI11 Grants from Abbott Italy that had no role in the design, analyses,

interpretation of data or in the decision to submit the abstract, Campoverde di Aprilia (LT), Italy

PGI12 Astrazeneca, Barcelona, SpainPGI13 Bristol Myers Squibb, Istanbul, TurkeyPGI14 Novartis Pharmaceuticals, Mexico City, MexicoPGI15 NonePGI16 Roche, São Paulo, BrazilPGI17 Ethicon Endo-Surgery (Europe) GmbH, Norderstedt,

GermanyPGI18 AstraZeneca, Oslo, NorwayPGI19 AstraZeneca, Mölndal, SwedenPGI20 Shire Development Inc., Wayne, PA, USAPGI21 Shire Pharmaceuticals, Wayne, PA, USAPGI22 Movetis, Turnhout, BelgiumPGI23 Ironwood Pharmaceuticals, Cambridge, MA, USA; Forest Research

Institute, Jersey City, NJ, USAPGI24 NonePGI25 Forest Research Institute, Jersey City, NJ, USA; Ironwood

Pharmaceuticals, Cambridge, MA, USAPGI26 AstraZeneca, Athens, GreecePGI27 AstraZeneca, Madrid, SpainPGI28 Pfi zer Spain, Madrid, SpainPGI29 NonePGI30 BAH e.V., Berlin, GermanyPGI31 Hamdard university, Islamabad, PakistanPGI32 NonePHP1 NonePHP2 Eli Lilly and Company, Indianapolis, IN, USAPHP3 PriceSpective, London, UKPHP4 NonePHP5 NonePHP6 NonePHP7 NonePHP8 Quality Plan for the National Health System, the Carlos III Institute of

Health, Madrid, SpainPHP9 Belgian Health Care Knowledge Centre, Brussel, BelgiumPHP10 NonePHP11 NonePHP12 NonePHP13 NonePHP14 NonePHP15 None

PHP16 NonePHP17 NonePHP18 NonePHP19 NonePHP20 NonePHP21 NonePHP22 NonePHP23 GfK HealthCare, London, UKPHP24 Belgian Health Care Knowledge Centre, Brussel, BelgiumPHP25 NonePHP26 NonePHP27 RQRUM, Montréal, QC, Canada; Pfi zer, Montréal, QC, Canada;

Sanofi -Aventis, Montréal, QC, CanadaPHP28 Association of the British Pharmaceutical Industry, London, UKPHP29 NonePHP30 Ministry of Health and Education, Tehran, IranPHP31 NonePHP32 NonePHP33 NonePHP34 NonePHP35 NonePHP36 NonePHP37 Consortium for Research on Equity and Health Systems (CREHS),

London, UKPHP38 NonePHP39 NonePHP40 NonePHP42 Novartis, Basel, SwitzerlandPHP43 NonePHP44 NonePHP45 NonePHP46 Belgian Health Care Knowledge Centre, Brussel, BelgiumPHP47 NonePHP48 NonePHP49 NonePHP50 NonePHP51 NonePHP52 KKH-Allianz, Hannover, GermanyPHP53 Ankara University, Ankara, TurkeyPHP54 NonePHP55 NonePHP56 South African Pharmacy Council, Pretoria, South AfricaPHP57 NonePHP58 NonePHP59 Ministry of Finance, Brasilia, BrazilPHP60 NonePHP61 NonePHP62 NonePHP63 NonePHP64 NonePHP65 NonePHP66 Heron Evidence Development, Luton, UKPHP67 CSD EPIC, London, UKPHP68 NonePHP69 NonePHP70 NonePHP71 National Health Research Institutes, Zhunan, Taiwan; National Science

Council, Taipei, TaiwanPHP72 NonePHP73 NonePHP74 NonePHP75 NonePHP76 NonePHP77 GlaxoSmithKline GmbH & Co., KG, Munich, GermanyPHP78 RTI Health Solutions, Research Triangle Park, NC, USAPHP79 NonePHP80 NonePHP81 NonePHP82 NonePHP83 NonePHP84 NonePHP85 NonePHP86 Health Care Insurance Board The Netherlands, Diemen, The

NetherlandsPHP87 ZonMw, Den Haag, The NetherlandsPHP88 NonePHP89 Bristol-Myers Squibb, Rueil Malmaison, France; REGISTRAT-MAPI, Lyon,

FrancePHP90 None




PHP91 NonePHP92 Quality Plan for the National Health System, the Carlos III Institute of

Health, Madrid, SpainPHP93 Axea Pharma, Lindau, GermanyPHP94 Costello Medical Consulting Limited, Cambridge, UKPHP95 GfK NOP, London, UKPHP96 NonePHP97 NonePHP98 Costello Medical Consulting Limited, Cambridge, UKPHP99 NonePHP100 NonePHP101 NonePHP102 NonePHP103 Bristol-Myers Squibb, Uxbridge, UKPHP104 European Commission, Brussels, BelgiumPHP105 NonePHP106 Offi ce of Health Economics, London, UK; City University, London, UKPHP107 NonePHP108 NonePHP109 NonePHP110 NonePHP111 NonePHP112 Sanofi -Aventis, Paris, France; Qatar Telecomunications Company, Doha,

QatarPHP113 NonePHP114 NonePHP115 Dutch Ministry of Health, Wellbeing and Sports, Den Haag, The

NetherlandsPHP116 NonePHP117 NonePHP118 NonePHP119 Ethicon, Somerville, NJ, USAPHP120 NonePHP121 NonePHP122 Ministry of National Development and Economics, Budapest, HungaryPHP123 NonePHP124 NonePHP125 Complete Market Access, Macclesfi eld, UKPHP126 Double Helix Consulting, London, UKPHP127 The National Institute for Health Policy and Health Services Research,

Ramat Gan, IsraelPHP128 NonePHP129 NonePHP130 NonePHP131 NonePHP132 NonePHP133 NonePHP134 Ethicon, Inc., Somerville, NJ, USAPHP135 NonePIH1 NonePIH2 NonePIH3 NonePIH4 GlaxoSmithKline, Wavre, BelgiumPIH5 NonePIH6 GlaxoSmithKline, Wavre, BelgiumPIH7 NonePIH8 NonePIH9 NonePIH10 Bayer Schering Pharma AG, Berlin, GermanyPIH11 GSK Biologicals, Wavre, BelgiumPIH12 European Comission—BASILEUS Western Balcans Academic Exchange

Grant, Ghent, Belgium; Ministry of Science and technological Development, Grant N. 145005, The Republic of Serbia, Kragujevac, Serbia and Montenegro

PIH13 NonePIH14 NonePIH15 Amgen (Austria), Vienna, AustriaPIH16 NonePIH17 GSK, Inc., Philadelphia, PA, USAPIH18 GlaxoSmithKline, Tres Cantos (Madrid), SpainPIH19 NonePIH20 Johnson & Johnson, São Paulo, BrazilPIH21 Wyeth, Hoofddorp, The NetherlandsPIH22 GlaxoSmithKline, Philadelphia, PA, USAPIH23 GlaxoSmithKline, Solna, SwedenPIH24 NonePIH25 NonePIH26 Regione Lombardia, Milan, ItalyPIH27 None

PIH28 Axea Pharma, Lindau, Germany; Boehringer Ingelheim, Ingelheim am Rheim, Germany

PIH29 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPIH30 NonePIH31 NonePIH32 GlaxoSmithKline UK Ltd., Uxbridge, UKPIH33 Pfi zer Ltd., Sandwich, UKPIH34 Eli Lilly and Company, Indianapolis, IN, USAPIH35 NonePIH36 Merck Serono, Madrid, SpainPIH37 NonePIH38 PFSA, Boulogne, FrancePIH39 PFSA, Boulogne, FrancePIH40 Bayer Schering Pharma AG, Berlin, GermanyPIH41 Servier Science Union, Suresnes, FrancePIH42 NonePIH43 NonePIH44 NonePIH45 Sociedad Española de Contracepción, Madrid, SpainPIH46 NonePIH47 NonePIH48 National Research Foundation (NRF), Pretoria, South AfricaPIH49 Nelson Mandela Metropolitan University, Port Elizabeth, South AfricaPIH50 JRDS ePharma Health, Delhi, IndiaPIH51 NonePIH52 NonePIH53 Universiti Sains Malaysia, Penang, MalaysiaPIH54 NonePIH55 PFSA, Boulogne, FrancePIH56 NonePIH57 Spanish National I+D program (PI1346/09), Madrid, SpainPIH58 GlaxoSmithKline, Wavre, BelgiumPIH59 NonePIH60 GSK, Inc., Philadelphia, PA, USAPIH61 Sanofi Pasteur MSD, Lyon, FrancePIH62 GSK, Inc., Philadelphia, PA, USAPIH63 NonePIH64 NonePIH65 Federal Ministry of Education and Research, Berlin, GermanyPIH66 Kendle International Inc., Wilmington, NC, USAPIN1 Pfi zer, New London, CT, USAPIN2 Johnson & Johnson Pharmaceutical Services, Raritan, NJ, USAPIN3 NonePIN4 GSK Biologicals, Rixensart, BelgiumPIN5 NonePIN6 NonePIN7 Pfi zer Spain, Madrid, SpainPIN8 NonePIN9 NonePIN10 Janssen-Cilag GmbH, Neuss, GermanyPIN11 Carlos III Health Institute, Madrid, SpainPIN12 Bayer Healthcare, Wayne, NJ, USAPIN13 GlaxoSmithKline, Philadelphia, PA, USAPIN14 Pfi zer Pharamaceuticals Korea Ltd., Seoul, South KoreaPIN15 Ethicon, Somerville, NJ, USAPIN16 NonePIN17 NonePIN18 GlaxoSmithKline, Wavre, BelgiumPIN19 NonePIN20 Bayer Healthcare, Wayne, NJ, USAPIN21 GlaxoSmithKline, Philadelphia, PA, USAPIN22 Bristol-Myers Squibb, Madrid, SpainPIN23 NonePIN24 NonePIN25 Centers for Disease Control and Prevention, Atlanta, GA, USAPIN26 Bristol-Myers Squibb, Uxbridge, UKPIN27 GlaxoSmithKline, Verona, ItalyPIN28 Sanofi Pasteur MSD, Lyon, FrancePIN29 NonePIN30 Novartis Pharma, Barcelona, SpainPIN31 Wyeth, Muenster, GermanyPIN32 GSK, Hong Kong, ChinaPIN33 NonePIN34 Merck & Co., Inc., Whitehouse Station, NJ, USAPIN36 NonePIN37 GlaxoSmithKline, Rio de Janeiro, BrazilPIN38 GlaxoSmithKline, Philadelphia, PA, USAPIN39 NonePIN40 None




PIN41 Sanofi Pasteur MSD, Lyon, FrancePIN42 Pfi zer Limited, Taipei County, TaiwanPIN43 NonePIN44 Roche, Shanghai, ChinaPIN45 Roche Farma, Madrid, SpainPIN46 Baxter, Brussel, BelgiumPIN47 NonePIN48 NonePIN49 NonePIN50 NonePIN51 SPMSD, Lyon, FrancePIN52 Merck & Co., Inc., Whitehouse Station, NJ, USA; Whitehouse Station,

NJ, USAPIN53 Pfi zer Spain, Madrid, SpainPIN54 Abbott, Abbott Park, IL, USAPIN55 Janssen-Cilag, Neuss, GermanyPIN56 NonePIN57 NonePIN58 Provincial Government of the Western Cape, Cape Town, South AfricaPIN59 Roche Farma, Madrid, SpainPIN60 NonePIN61 NonePIN62 GlaxoSmithKline, Philadelphia, PA, USAPIN63 Bristol-Myers Squibb, Braine—L’Alleud, BelgiumPIN64 Sanofi Pasteur MSD, Maidenhead, UKPIN65 Sanofi Pasteur MSD, Lyon, FrancePIN66 NonePIN67 Janssen-Cilag GmbH, Neuss, GermanyPIN68 HIRA, Seoul, South KoreaPIN69 NonePIN70 Centre for Health Economics, York, UKPIN71 MedImmune LLC, Gaithersburg, MD, USAPIN72 Ministry of Finance, Brasilia, BrazilPIN73 NonePIN74 NonePIN75 Janssen-Cilag, Neuss, GermanyPIN76 NonePIN77 GlaxoSmithKline, Wavre, BelgiumPIN78 NonePIN79 Bristol-Myers Squibb, Braine—L’Alleud, BelgiumPIN80 Novartis Pharma AG, Basel, SwitzerlandPMC1 NonePMC2 GlaxoSmithKline UK, London, UKPMC3 Analytica International, New York, NY, USAPMC4 NonePMC5 Pfi zer, Inc., New York, NY, USAPMC6 NonePMC7 NonePMC8 NonePMC9 NonePMC10 Agency for Health Technology Assessment in Poland, Warszawa, PolandPMC11 NonePMC12 GSK France, Marly-le-Roi, FrancePMC13 NonePMC14 NonePMC15 NonePMC16 CSD EPIC, London, UKPMC17 NonePMC18 NonePMC19 Shire Pharmaceuticals, Wayne, PA, USAPMC20 NonePMC21 NonePMC22 NonePMC23 Shire Pharmaceuticals, Wayne, PA, USAPMC24 Bayer, Wayne, NJ, USAPMC25 Lacey Solutions Ltd., Skerries, IrelandPMC26 NonePMC27 EuroQoL Group, Rotterdam, The NetherlandsPMC28 NonePMC29 NonePMC30 NonePMC31 Health Utilities Inc., Dundas, ON, CanadaPMC32 Pfi zer Spain, Madrid, SpainPMC33 NonePMC34 NonePMC35 NonePMC36 NonePMC37 NonePMC38 Oxford Outcomes, Oxford, UK

PMC39 NonePMC40 NIH/NIA, Bethesda, MD, USA; QualityMetric Inc., Lincoln, RI, USAPMC41 NonePMC42 NonePMC43 NonePMC44 NonePMC45 NonePMC46 NonePMC47 CRF Health, Helsinki, FinlandPMC48 NonePMC49 NonePMC50 NonePMC51 NonePMC52 NonePMC53 NonePMC54 Bayer Schering Pharma AG, Berlin, UKPMC55 European Commission under the Lifelong Learning Programme,

Warsaw, PolandPMC56 NonePMC57 ICON Clinical Research, San Francisco, CA, USAPMC58 European Commission under the Lifelong Learning Programme,

Warsaw, PolandPMC59 NonePMC60 HERON Evidence Development Ltd., Luton, UKPMC61 NonePMH1 Pfi zer Limited, Walton Oaks, UKPMH2 Eli Lilly, Sydney, AustraliaPMH3 Eli Lilly and Company, Indianapolis, IN, USAPMH4 AstraZeneca, Naucalpan, MexicoPMH5 Janssen-Cilag, Neuss, GermanyPMH6 KVBaWue, Stuttgart, Germany; vdek, Stuttgart, GermanyPMH7 NonePMH8 the Ministry of Health, Labor and Welfare, Japan, Tokyo, JapanPMH9 Lundbeck Poland Sp z o.o., Warsaw, PolandPMH10 National Research Foundation, Pretoria, South AfricaPMH11 Sanofi -Aventis Poland, Warszawa, PolandPMH12 Pfi zer, Stockholm, SwedenPMH13 Pfi zer, Inc., New York, NY, USAPMH14 Bristol-Myers Squibb, Madrid, SpainPMH15 AstraZeneca R&D, Mölndal, SwedenPMH16 AstraZeneca R&D, Mölndal, SwedenPMH17 NonePMH18 Servier (Suisse) SA, Meyrin, SwitzerlandPMH19 Medtronic, Inc., Minneapolis, MN, USAPMH20 Janssen-Cilag GmbH, Neuss, GermanyPMH21 AstraZeneca, Södertälje, SwedenPMH22 Pfi zer Deutschland GmbH, Berlin, Germany; Eisai GmbH, Frankfurt am

Main, Germany; AOK-Bavaria—Health Iinsurer, Nürnberg, Germany; Federal Association of the AOK, Berlin, Germany

PMH23 National Institute of Mental Health, Washington, DC, USAPMH24 NonePMH25 NonePMH26 Universiti Sains Malaysia, Penang, MalaysiaPMH27 Substance Abuse and Mental Health Services Agency, Bethesda, MD,

USAPMH28 Pfi zer Spain, Madrid, SpainPMH29 Bristol-Myers Squibb, Madrid, SpainPMH30 Servier Ireland, Dublin, IrelandPMH31 Bristol Myers Squibb Pharmaceuticals Ltd., Uxbridge, UKPMH32 Servier Hungary, Budapest, HungaryPMH33 Bristol-Myers Squibb, Braine-l’Alleud, BelgiumPMH34 NonePMH35 Lundbeck SAS, ISSY les MouiIneaux, FrancePMH36 BMS, Madrid, SpainPMH37 Janssen-Cilag, Spain, SpainPMH38 AstraZeneca UK Ltd., Luton, EnglandPMH39 Servier Polska Sp. z o.o., Warsaw, PolandPMH40 Lundbeck Poland Sp z o.o., Warsaw, PolandPMH41 Lundbeck, Issy-les-Moulineaux, FrancePMH42 NonePMH43 Eli Lilly and Company, Bad Homburg, GermanyPMH44 AstraZeneca, Södertälje, SwedenPMH45 Ortho-McNeil Janssen Scientifi c Affairs, LLC, Bethesda, MD, USAPMH46 NonePMH47 National Health Research Institutes, Jhunan County, TaiwanPMH48 AstraZeneca, Budapest, HungaryPMH49 NonePMH50 NonePMH51 Faber Stiftung, Marburg, Germany




PMH52 FIS PI08/90812, Madrid, Spain; BIOEF BIO09/EM/001, Bilbao, SpainPMH53 NonePMH54 NonePMH55 AstraZeneca, Madrid, SpainPMH56 NonePMH57 NonePMH58 Janssen Alzheimer Immunotherapy, Dublin, IrelandPMH59 BristomMyersSquibb, Brussels, BelgiumPMH60 AstraZeneca, Brussels, BelgiumPMH61 Lundbeck SAS, Issy-les-Moulineaux, FrancePMH62 NonePMH63 National Research Foundation (NRF), Pretoria, South AfricaPMH64 Lundbeck, Paris, FrancePMH65 DAHTA@DIMDI, Cologne, GermanyPMH66 NonePMH67 NonePMH68 Janssen Cilag, Neuss, GermanyPMH69 Janssen Cilag, Neuss, GermanyPMH70 NonePMH71 ZonMw, The Hague, The NetherlandsPMH72 NonePMH73 NonePMS1 Takeda Pharmaceuticals International, Inc., Deerfi eld, IL, USAPMS2 Amgen Inc., Thousand Oaks, CA, USAPMS3 Medtronic, Tolochenaz, SwitzerlandPMS4 UCB, Brussels, BelgiumPMS5 Alberta Health and Wellness grant from three pharmaceutical

companies, Edmonton, AB, CanadaPMS6 NonePMS7 NonePMS8 NonePMS9 NonePMS10 Takeda Pharmaceuticals International, Inc., Deerfi eld, IL, USAPMS11 Novartis Farma spa, Varese, ItalyPMS12 Heraeus Medical GmbH, Wehrheim, GermanyPMS13 Heraeus Medical GmbH, wehrheim, GermanyPMS14 NonePMS15 Novartis Pharma, Basel, SwitzerlandPMS16 NonePMS17 Medtronic Spinal and Biologics, Memphis, TN, USAPMS18 Roche S.p.A, Monza, ItalyPMS19 NonePMS20 BMS, Seoul, South KoreaPMS21 Amgen Canada, Burlington, ON, CanadaPMS22 AMGEN, Neuilly sur Seine, FrancePMS23 Amgen, Vienna, AustriaPMS24 Amgen Dompè S.p.A., Milano, ItalyPMS25 NonePMS26 NonePMS27 Ministry of Health, Labor and Welfare, Tokyo, JapanPMS28 Abbott Laboratories, Madrid, SpainPMS29 Amgen, Vienna, AustriaPMS30 North-West University, Potchefstroom, South AfricaPMS31 Pfi zer, Collegeville, PA, USAPMS32 Medtronic Italy, Milan, ItalyPMS33 Productos Roche S.A. de C.V., México, MexicoPMS34 Schering-Plough Corp, Welwyn Garden City, UKPMS35 Eli Lilly and Company, Indianapolis, IN, USAPMS36 NonePMS37 Bristol-Myers Squibb, Uxbridge, UKPMS38 Roche México, México, MexicoPMS39 NonePMS40 Amgen, Zug, SwitzerlandPMS41 Amgen Europe, Zug, SwitzerlandPMS42 UCB, Brussels, BelgiumPMS43 Roche Oy, Espoo, FinlandPMS44 NonePMS45 NonePMS46 Eli Lilly and Company, Indianapolis, IN, USAPMS47 Eli Lilly and Company, Indianapolis, IN, USAPMS48 NonePMS49 NonePMS50 Merck & Co., Whitehouse Station, NJ, USAPMS51 Nycomed Pharma, Madrid, SpainPMS52 Merck & Co., Inc., Whitehouse Station, NJ, USAPMS53 Roche Hellas SA., Athens, GreecePMS54 Servier Hungaria Kft, Budapest, Hungary; Centre for Public Affairs

Studies Foundation, Budapest, HungaryPMS55 None

PMS56 NonePMS57 NonePMS58 Eli Lilly and Company, Indianapolis, IN, USAPMS59 NonePMS60 NonePMS61 Merck Sharp & Dohme, Madrid, SpainPMS62 UCB, Brussels, BelgiumPMS63 NonePMS64 Charles University, Prague, Czech RepublicPMS65 Genentech, South San Francisto, CA, USAPMS66 Finnish Medicines Agency, Helsinki, FinlandPMS67 Ministry of Health, Labor and Welfare, Tokyo, JapanPMS68 Merck & Co., Inc., Whitehouse Station, NJ, USAPMS69 PFSA, Boulogne, FrancePMS70 PFSA, Boulogne Cedex, FrancePMS71 Bristol-Myers Squibb, Uxbridge, UKPMS72 Bayer, São Paulo, BrazilPMS73 Thomson Reuters, Cambridge, MA, USAPMS74 NonePMS75 Wyeth, Maidenhead, UKPMS76 NonePMS77 NonePMS78 NonePMS79 NonePND1 Teva Pharmaceuticals, Kansas City, MO, USAPND2 NonePND3 NonePND4 National Institute for Health Technlogy Assessment (IATS)—Brazil,

Porto Alegre, BrazilPND5 Eisai, Woodcliff Lake, NJ, USAPND6 National Institute for Health Technlogy Assessment (IATS), NPq, Brazil,

Porto Alegre, BrazilPND7 Biogen Idec, Wellesley, MA, USAPND8 Covidien, Zurich, SwitzerlandPND9 NonePND10 Novartis, São Paulo, Brazil; Novartis, Flohram Park, NJ, USAPND11 MerckSerono UK, Feltham, UKPND12 University Claude Bernard Lyon 1, Lyon, FrancePND13 NonePND14 Biogen Idec, Vienna, AustriaPND15 NonePND16 Janssen-Cilag, Neuss, GermanyPND17 Lundbeck SAS, Issy-Les-Moulineaux, FrancePND18 NonePND19 Biogen Idec GmbH, Munich, GermanyPND20 Glaxo SmithKline, Zeist, The NetherlandsPND21 UCB MEXICO, Mexico D.F., MexicoPND22 NonePND23 NonePND24 BiogenIdec, Cambridge, MA, USAPND25 Biogen Idec, Vienna, AustriaPND26 UCB Pharma S.A., Brussels, BelgiumPND27 Abbott Product Operations AG, Allschwil, SwitzerlandPND28 UCB S.A., Brussels, BelgiumPND29 MSD Sweden, Sollentuna, SwedenPND30 UCB Pharma S.A., Brussels, BelgiumPND31 NonePND32 NonePND33 NonePND34 Teva Neuroscience, Kansas City, MO, USAPND35 NonePND36 Teva Neuroscience, Kansas City, MO, USAPND37 Novartis Pharma, Barcelona, SpainPND38 NonePND39 Merck Serono, S.A., Geneva, SwitzerlandPND40 University Claude Bernard Lyon 1, Lyon, FrancePND41 Grunenthal GmbH, Aachen, GermanyPND42 NonePND43 Lundbeck Canada, Montreal, QC, CanadaPND44 NonePND45 Cyberonics, Zaventem, BelgiumPND46 Merck Serono, S.A., Geneva, SwitzerlandPND47 Merck Sharp & Dohme, Madrid, SpainPND48 Allergan, Inc., Irvine, CA, USAPRS1 Abbott Laboratories, Montreal, QC, CanadaPRS2 Abbott Laboratories, Montreal, QC, CanadaPRS3 GlaxoSmithKline R&D, Greenford, UKPRS4 Pfi zer, Spain, Madrid, SpainPRS5 AstraZeneca UK Ltd., Luton, UK




PRS6 The Netherlands Asthma Foundation, Amersfoort, The NetherlandsPRS7 NYCOMED Sp. z o. o., Warsaw, PolandPRS8 NYCOMED Sp. z o. o., Warsaw, PolandPRS9 GlaxoSmithKline, London, EnglandPRS10 NonePRS11 GSK, Hong Kong, ChinaPRS12 NonePRS13 Novartis Pharma, Barcelona, SpainPRS14 Covidien, Zurich, SwitzerlandPRS15 Covidien, Zurich, SwitzerlandPRS16 AstraZeneca, Budapest, HungaryPRS17 Nycomed S.p.a, Milan, ItalyPRS18 AstraZeneca Nordic, Södertälje, SwedenPRS19 Quintiles, Rockville, MD, USAPRS20 NonePRS21 NonePRS22 NonePRS23 NonePRS24 Dutch Government Ministry of Health, Den Haag, The NetherlandsPRS25 Boehringer Ingelheim Italy, Milan, ItalyPRS26 Mantecorp, São Paulo, BrazilPRS27 Nycomed BV, Hoofddorp, The NetherlandsPRS28 GSK, Mexico D.F., MexicoPRS29 GSK, Mexico D.F., MexicoPRS30 NonePRS31 GlaxoSmithKline Russia, Moscow, RussiaPRS32 GlaxoSmithKline Russia, Moscow, RussiaPRS33 Bayer Healthcare, Barcelona, SpainPRS34 AstraZeneca Nordic, Södertälje, SwedenPRS35 Chiesi España, Barcelona, SpainPRS36 NonePRS37 AstraZeneca, Macclesfi eld, UKPRS38 NonePRS39 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefi eld, CT, USA; Pfi zer

Inc., New York, NY, USAPRS40 Pfi zer B.V., Capelle a/d IJssel, The NetherlandsPRS41 Merck Sharp & Dohme, Madrid, SpainPRS42 Canadian Institutes for Health Research, Ottawa, ON, Canada; AllerGen

Network Centre for Excellence, Hamilton, ON, CanadaPRS43 Novartis, Origgio, ItalyPRS44 Essex Pharma, Munich, GermanyPRS45 NonePRS46 Pfi zer Inc., New York, NY, USA; Boehringer Ingelheim GmbH,

Ingelheim, GermanyPRS47 NonePRS48 NonePRS49 NonePRS50 Forest Research Institute, Jersey City, NJ, USAPRS51 NonePR1 NonePR2 Top Institute Pharma, Leiden, The NetherlandsPR3 NonePR4 NonePSS1 Nestlé Nutrition Institute, Vevey, SwitzerlandPSS2 Janssen-Cilag GmbH, Neuss, GermanyPSS3 Basilea Pharmaceutica S.r.l., Milano, ItalyPSS4 Basilea Pharmaceutica, Basel, SwitzerlandPSS5 alcon france, rueil-malmaison, FrancePSS6 Abbott Scandinavia AB, Solna, SwedenPSS7 NonePSS8 ALCON, Puurs, BelgiumPSS9 Alcon France, Rueil-Malmaison, FrancePSS10 APA Parafricta Ltd., Newport Pagnell, UKPSS11 NonePSS12 Novartis (Hellas) S.A.C.I., Athens, GreecePSS13 Allergan, Bucks, UKPSS14 Janssen-Cilag, Kiev, UkrainePSS15 NonePSS16 Nestlé Nutrition Institute, Vevey, SwitzerlandPSS17 Nestlé Nutrition Institute, Vevey, SwitzerlandPSS18 Nestlé Nutrition Institute, Vevey, SwitzerlandPSS19 Eye Hospital, Rotterdam, The NetherlandsPSS20 Novartis Pharma, Basel, SwitzerlandPSS21 Astellas Pharma Europe Ltd., Staines, UKPSS22 GSK Biologicals, Wavre, BelgiumPSS23 NonePSS24 Alcon, Puurs, BelgiumPSS25 Alcon Laboratories, Puurs, BelgiumPSS26 Intendis GmbH, Berlin, Germany

PSS27 Eau Thermale Avene, Lavaur, FrancePSS28 Abbott France, Rungis, FrancePSS29 L’Oreal Research International, Paris, FrancePSS30 NonePSS31 Alcon France, Rueil-Malmaison, FrancePSS32 NonePSS33 Janssen-Cilag GmbH, Neuss, GermanyPSS34 NonePSS35 Basilea Pharmaceutica, Basel, SwitzerlandPSS36 Alcon France, Rueil-Malmaison, FrancePSS37 Alcon France, Rueil-Malmaison, FrancePSS38 Pfi zer Ltd., Walton, UKPSY1 Roche Spain, Madrid, SpainPSY2 NonePSY3 EISAI, San Donato Milanese, ItalyPSY4 Schering Plough, Kenilworth, NJ, USAPSY5 Novartis Pharmaceuticals UK Limited, Frimley, UKPSY6 Shire Human Genetic Therapies, Danderyd, SwedenPSY7 Novo Nordisk Pharma, Warsaw, PolandPSY8 Janssen Cilag GmbH, Neuss, GermanyPSY9 CSL Behring, Esplugues de Llobregat, SpainPSY10 Grünenthal GmbH, Aachen, GermanyPSY11 Janssen-Cilag, São José dos Campos, BrazilPSY12 Vifor AG, Villars-sur-Glane, Switzerland; Vifor Pharma International,

Glattbrugg, SwitzerlandPSY13 Pfi zer, Sollentuna, SwedenPSY14 Eli Lilly and Company, Indianapolis, IN, USAPSY15 Pfi zer, São Paulo, BrazilPSY16 Eli Lilly and Company, Indianapolis, IN, USAPSY17 NonePSY18 CSL Behring, Esplugues de Llobregat, SpainPSY19 Eli Lilly and Company, Indianapolis, IN, USAPSY20 GlaxoSmithKline, Uxbridge, UK; Human Genome Sciences, Rockville,

MD, USAPSY21 Consorzio Mario Negri Sud, Santa Maria Imbaro, ItalyPSY22 NonePSY23 NonePSY24 Bristol-Myers Squibb México, Mexico, MexicoPSY25 Amgen (Spain), Barcelona, Sri LankaPSY26 NonePSY27 Amgen SA/NV, Brussels, BelgiumPSY28 Bayer Healthcare, Barcelona, SpainPSY29 NonePSY30 Medtronic Italia, Sesto San Giovanni, ItalyPSY31 Merck Canada Inc., Montreal, QC, CanadaPSY32 GlaxoSmithKline, Dublin, IrelandPSY33 NonePSY34 Grünenthal GmbH, Aachen, GermanyPSY35 Eli Lilly and Company, Indianapolis, IN, USAPSY36 Baxter Healthcare, Zurich, SwitzerlandPSY37 Janssen-Cilag, São Paulo, BrazilPSY38 Schering-Plough Corp, Welwyn Garden City, UKPSY39 CVZ (Dutch Health Care Insurance Board), Diemen, The NetherlandsPSY40 Pfi zer Spain, Madrid, SpainPSY41 Janssen-Cilag, Bogota, ColombiaPSY42 Janssen-Cilag Farmaceutica Ltda., São Paulo, BrazilPSY43 Roche Farmacêutica Química, Portugal, Amadora, PortugalPSY44 Gruenenthal GmbH, Aachen, GermanyPSY45 Pfi zer, Tadworth, UKPSY46 NonePSY47 Grunenthal Ltd., Stokenchurch, UKPSY48 Johnson & Johnson, São Paulo, BrazilPSY49 Verein zur Förderung der Rehabilitationsforschung in Hamburg,

Mecklenburg-Vorpommern und Schleswig-Holstein e.V., Lübeck, Germany

PSY50 NonePSY51 Grünenthal GmbH, Aachen, GermanyPSY52 Johnson & Johnson/Centocor, Malvern, PA, USAPSY53 NonePSY54 Grunenthal GmbH, Aachen, GermanyPSY55 NonePSY56 GlaxoSmithKline, London, UK; Human Genome Sciences, Rockville, MD,

USAPSY57 Eli Lilly & Co., Indianapolis, IN, USAPSY58 Federal Ministry of Education and Research, Berlin, GermanyPSY59 NonePSY60 JRDS ePharma Health, Delhi, IndiaPSY61 NonePSY62 CNPq, Brazil, Brazil




PSY63 Actelion Pharmaceuticals, Allschwil, SwitzerlandPSY64 Amgen S.A., Barcelona, SpainPSY66 Covance, Gaithersburg, MD, USAPSY67 GlaxoSmithKline, Research Triangle Park, NC, USAPSY68 ANRS, Paris, FrancePUK1 NonePUK2 Baxter Healthcare Corporation, Deerfi eld, IL, USAPUK3 Novartis Pharmaceuticals, East Hanover, NJ, USAPUK4 Wyeth Pharmaceuticals Korea, Seoul, South KoreaPUK5 NonePUK6 NonePUK7 Shire Pharmaceuticals, Wayne, PA, USAPUK8 Novartis, Mexico, MexicoPUK9 F. Hoffmann-La Roche Ltd., Basel, SwitzerlandPUK10 NonePUK11 Baxter Healthcare Corporation, Deerfi eld, IL, USAPUK12 Bristol-Myers Squibb, Braine l’Alleud, BelgiumPUK13 GlaxoSmithKline, Marly le Roi, FrancePUK14 NonePUK15 Baxter, Brussels, BelgiumPUK16 NonePUK17 Baxter Healthcare Corporation, Braine l’Alleud, BelgiumPUK18 NonePUK19 Novartis, Mexico, MexicoPUK20 Shire Pharmaceuticals, Wayne, PA, USA

PUK21 Wyeth Pharmaceuticals Korea, Seoul, South KoreaPUK22 Abbott GmbH & Co. KG, Wiesbaden, Germany, Wiesbaden, GermanyPUK23 Vzw Wevenef, Antwerpen, BelgiumPUK24 Amgen Europe GmbH, Zug, SwitzerlandPUK25 NonePUK26 Shire Pharmaceuticals plc., Wayne, PA, USAPUK27 F. Hoffmann-La Roche Ltd., Basel, SwitzerlandPUK28 Bristol-Myers Squibb, Braine l’Alleud, BelgiumPUK29 Bristol-Myers Squibb, Bruxelles, BelgiumPUK30 Pfi zer Spain, Madrid, SpainPUK31 Pfi zer Spain, Madrid, SpainPUK32 Astellas Pharma Global Development—EU, Leiderdorp, The

NetherlandsPUK33 Astellas Pharma Global Development—EU, AC Leiderdorp, The

NetherlandsPUK34 Pfi zer Spain, Madrid, SpainPUK35 PFSA, Boulogne, FranceRS1 NoneRS2 IHS, Denver, CO, USARS3 NoneRS4 NoneVA1 GSK Bio, Wavre, BelgiumVA2 NoneVA3 NoneVA4 NUFFIC, Den Haag, The Netherlands



ispor 13th annual european congress disclosure information

Documents